2m 2m 2m 2m 2m 2m 2m
- $318.0MMarket Cap
- 33.69%1-Year Change
- Medical DevicesIndustry
908 DEVICES (MASS)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 63
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
908 Devices (MASS) Q2 Revenue Jumps 14%
908 Devices reported Q2 2025 revenue of $13.0 million, a 14% year-over-year increase, but experienced margin pressures and widened net losses. The company continues strategic investments and restructuring while targeting EBITDA break-even in Q4 2025.
08/05/2025, 10:31 PM • The Motley Fool
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.
Key Executives
- Kevin J. Knopp
- Joseph H. Griffith
- John Kenneweg
- Christopher David Brown
- Mark S. Levine
Current Ownership Distribution
- Institutions387.9M (71.09%)
- Mutual Funds144.4M (26.47%)
- Insiders13.3M (2.44%)
- Other0 (0.00%)